{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:03:40Z","timestamp":1779955420801,"version":"3.53.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,28]]},"DOI":"10.7759\/cureus.109789","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:26:11Z","timestamp":1779953171000},"source":"Crossref","is-referenced-by-count":0,"title":["Biochemically Evolving Acute Hepatic Porphyria With Postpartum Progression to Severe Recurrent Neurovisceral Disease"],"prefix":"10.7759","author":[{"given":"Niyas Khalid","family":"Ottu Para","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy H","year":"2010","unstructured":"Puy H, Gouya L, Deybach JC. Porphyrias. Lancet. 2010, 375:924-37. 10.1016\/S0140-6736(09)61925-5","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-423186","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"120","author":"Balwani M","year":"2012","unstructured":"Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood. 2012, 120:4496-504. 10.1182\/blood-2012-05-423186","journal-title":"Blood"},{"key":"ref3","article-title":"Neurological manifestations of acute intermittent porphyria","volume":"55","author":"Pischik E","year":"2009","unstructured":"Pischik E, Kauppinen R. Neurological manifestations of acute intermittent porphyria. Cell Mol Biol (Noisy-le-grand). 2009, 55:72-83.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson KE","year":"2005","unstructured":"Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, Desnick RJ. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005, 142:439-50. 10.7326\/0003-4819-142-6-200503150-00010","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0004563212474555","article-title":"Best practice guidelines on clinical management of acute attacks of porphyria and their complications","volume":"50","author":"Stein P","year":"2013","unstructured":"Stein P, Badminton M, Barth J, Rees D, Stewart MF. Best practice guidelines on clinical management of acute attacks of porphyria and their complications. Ann Clin Biochem. 2013, 50:217-23. 10.1177\/0004563212474555","journal-title":"Ann Clin Biochem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-009-0261-4","article-title":"The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine","volume":"4","author":"Ventura P","year":"2009","unstructured":"Ventura P, Cappellini MD, Rocchi E. The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine. Intern Emerg Med. 2009, 4:297-308. 10.1007\/s11739-009-0261-4","journal-title":"Intern Emerg Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder G","year":"2013","unstructured":"Elder G, Harper P, Badminton M, Sandberg S, Deybach JC. The incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2013, 36:849-57. 10.1007\/s10545-012-9544-4","journal-title":"J Inherit Metab Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.06.040","article-title":"Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha","volume":"122","author":"Handschin C","year":"2005","unstructured":"Handschin C, Lin J, Rhee J, et al.. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell. 2005, 122:505-15. 10.1016\/j.cell.2005.06.040","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007139","article-title":"Acute porphyrias: pathogenesis of neurological manifestations","volume":"18","author":"Meyer UA","year":"1998","unstructured":"Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis. 1998, 18:43-52. 10.1055\/s-2007-1007139","journal-title":"Semin Liver Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1297","article-title":"Acute hepatic porphyrias: review and recent progress","volume":"3","author":"Wang B","year":"2019","unstructured":"Wang B, Rudnick S, Cengia B, Bonkovsky HL. Acute hepatic porphyrias: review and recent progress. Hepatol Commun. 2019, 3:193-206. 10.1002\/hep4.1297","journal-title":"Hepatol Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17744-7","article-title":"Porphyrias","volume":"365","author":"Kauppinen R","year":"2005","unstructured":"Kauppinen R. Porphyrias. Lancet. 2005, 365:241-52. 10.1016\/S0140-6736(05)17744-7","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30936","article-title":"EXPLORE: a prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks","volume":"71","author":"Gouya L","year":"2020","unstructured":"Gouya L, Ventura P, Balwani M, et al.. EXPLORE: a prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks. Hepatology. 2020, 71:1546-58. 10.1002\/hep.30936","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky HL","year":"2014","unstructured":"Bonkovsky HL, Maddukuri VC, Yazici C, et al.. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium. Am J Med. 2014, 127:1233-41. 10.1016\/j.amjmed.2014.06.036","journal-title":"Am J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12899","article-title":"Systemic inflammation in acute intermittent porphyria: a case-control study","volume":"187","author":"Storjord E","year":"2017","unstructured":"Storjord E, Dahl JA, Landsem A, et al.. Systemic inflammation in acute intermittent porphyria: a case-control study. Clin Exp Immunol. 2017, 187:466-79. 10.1111\/cei.12899","journal-title":"Clin Exp Immunol"},{"key":"ref15","article-title":"Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools","volume":"86","author":"Bonkovsky HL","year":"1991","unstructured":"Bonkovsky HL, Healey JF, Lourie AN, Gerron GG. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am J Gastroenterol. 1991, 86:1050-6.","journal-title":"Am J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807838","article-title":"Phase 1 trial of an RNA interference therapy for acute intermittent porphyria","volume":"380","author":"Sardh E","year":"2019","unstructured":"Sardh E, Harper P, Balwani M, et al.. Phase 1 trial of an RNA interference therapy for acute intermittent porphyria. N Engl J Med. 2019, 380:549-58. 10.1056\/NEJMoa1807838","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9142-2","article-title":"A retrospective analysis of outcome of pregnancy in patients with acute porphyria","volume":"33","author":"Marsden JT","year":"2010","unstructured":"Marsden JT, Rees DC. A retrospective analysis of outcome of pregnancy in patients with acute porphyria. J Inherit Metab Dis. 2010, 33:591-6. 10.1007\/s10545-010-9142-2","journal-title":"J Inherit Metab Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23067","article-title":"Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease","volume":"37","author":"Chen B","year":"2016","unstructured":"Chen B, Solis-Villa C, Hakenberg J, et al.. Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease. Hum Mutat. 2016, 37:1215-22. 10.1002\/humu.23067","journal-title":"Hum Mutat"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani M","year":"2020","unstructured":"Balwani M, Sardh E, Ventura P, et al.. Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria. N Engl J Med. 2020, 382:2289-301. 10.1056\/NEJMoa1913147","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03284-w","article-title":"Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1\/2, 48-month open-label extension study","volume":"19","author":"Sardh E","year":"2024","unstructured":"Sardh E, Balwani M, Rees DC, Anderson KE, Jia G, Sweetser MT, Wang B. Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1\/2, 48-month open-label extension study. Orphanet J Rare Dis. 2024, 19:365. 10.1186\/s13023-024-03284-w","journal-title":"Orphanet J Rare Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495164-biochemically-evolving-acute-hepatic-porphyria-with-postpartum-progression-to-severe-recurrent-neurovisceral-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:26:11Z","timestamp":1779953171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495164-biochemically-evolving-acute-hepatic-porphyria-with-postpartum-progression-to-severe-recurrent-neurovisceral-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.109789","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}